Company Description

Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States.

The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.

Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.

The company was founded in 2014 and is headquartered in Monrovia, California.

Invizyne Technologies, Inc.

Country	United States
Founded	2019
IPO Date	Nov 13, 2024
Industry	Specialty Chemicals
Sector	Materials
Employees	29
CEO	Michael Heltzen

Contact Details

Address: 750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States
Phone	626 415 1488
Website	invizyne.com

Stock Details

Ticker Symbol	IZTC
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$8.00
CIK Code	0002010788
ISIN Number	US4618741098
Employer ID	83-4550057
SIC Code	2836

Key Executives

Name	Position
Michael Heltzen	Chief Executive Officer
Fouad Nawaz	Vice President, Finance
Tyler Korman	Vice President, Research
Paul Opgenorth	Vice President, Development
Mo Hayat	Chairman of the Board, President
Christopher A. Marlett	Director
Anthony DiGiandomenico	Director
James U. Bowie	Director

Latest SEC Filings

Date	Type	Title
Nov 19, 2024	D	Notice of Exempt Offering of Securities
Nov 18, 2024	SC 13D	General statement of acquisition of beneficial ownership
Nov 18, 2024	SC 13D	General statement of acquisition of beneficial ownership
Nov 18, 2024	SC 13D	General statement of acquisition of beneficial ownership
Nov 18, 2024	SC 13D	General statement of acquisition of beneficial ownership
Nov 18, 2024	8-K	Current Report
Nov 12, 2024	10-Q	Quarterly Report
Nov 12, 2024	424B4	Prospectus
Nov 12, 2024	424B4	Prospectus
Nov 12, 2024	CERT	Certification by an exchange approving securities for listing

View All SEC Filings